BGMA: NHS must complete drug reimbursement reforms or face higher bill

NHS England and NHS Improvement (NHSE&I) will be forced to pay a “higher drugs bill” unless it “urgently” completes its planned drug reimbursement reforms, the head of the British Generic Manufacturers Association’s (BGMA) has told C+D.